Abstract
Rongyu Wang, Yingyu Luo, Liying Liu, Nannan Zhang
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
A new framework for the diagnosis, staging and management of obesity in adults
10.1038/s41591-024-03095-3 · 2024
Is Obesity or Adiposity-Based Chronic Disease Curable: The Set Point Theory, the Environment, and Second-Generation Medications
10.1016/j.eprac.2021.11.082 · 2022
10.20944/preprints202510.0332.v1
10.20944/preprints202510.0332.v1
Immunomodulation at epithelial sites by obesity and metabolic disease
10.1007/s12026-011-8261-7 · 2011
The inflammation highway: Metabolism accelerates inflammatory traffic in obesity
10.1111/j.1600-065x.2012.01151.x · 2012
Genetics of Oxidative Stress in Obesity
10.3390/ijms15023118 · 2014
The obesity-autophagy-cancer axis: Mechanistic insights and therapeutic perspectives
10.1016/j.semcancer.2024.01.003 · 2024
Oxidative stress: A concept in redox biology and medicine
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.1016/j.redox.2015.01.002 · 2015
10.3390/cells14201621
10.3390/cells14201621
The multifaceted contributions of mitochondria to cellular metabolism
10.1038/s41556-018-0124-1 · 2018
Mechanisms of obesity-induced metabolic and vascular dysfunctions
10.2741/4758 · 2019
10.3390/biom15010020
10.3390/biom15010020
Effects of Mitochondrial Dynamics in the Pathophysiology of Obesity
10.31083/j.fbl2703107 · 2022
Adipocyte hypertrophy parallels alterations of mitochondrial status in a cell model for adipose tissue dysfunction in obesity
10.1016/j.lfs.2020.118812 · 2021
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
10.1016/j.obpill.2024.100108 · 2024
10.3390/nu17162642
10.3390/nu17162642
Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
10.1007/s13679-022-00473-1 · 2022
10.3390/jpm10020042
10.3390/jpm10020042
The effects of magnesium supplementation on obesity measures in adults: A systematic review and dose-response meta-analysis of randomized controlled trials
10.1080/10408398.2020.1790498 · 2021
10.3390/nu13020320
10.3390/nu13020320
Role of Magnesium in Oxidative Stress in Individuals with Obesity
10.1007/s12011-016-0793-1 · 2017
10.3390/nu13020463
10.3390/nu13020463
Placental inflammation, oxidative stress, and fetal outcomes in maternal obesity
10.1016/j.tem.2024.02.002 · 2024
10.3390/nu14235125
10.3390/nu14235125
10.1186/s12916-023-02730-z
10.1186/s12916-023-02730-z
Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity
10.1038/nm.3735 · 2014
10.3390/ijms26178544
10.3390/ijms26178544
10.3389/fendo.2023.1134025
10.3389/fendo.2023.1134025
10.3390/ijms24097898
10.3390/ijms24097898
From Obesity to Muscle Insulin Resistance: The Mediating Roles of Intramyocellular Lipids, Inflammation, and Oxidative Stress
10.1002/dmrr.70094 · 2025
10.3389/fimmu.2024.1394869
10.3389/fimmu.2024.1394869
10.3390/genes16050489
10.3390/genes16050489
10.3389/fendo.2026.1709556
10.3389/fendo.2026.1709556
Mitochondrial uncoupling, energy substrate utilization, and brown adipose tissue as therapeutic targets in cancer
10.1038/s44324-025-00080-3 · 2025
Mitochondrial dysfunction in obesity
10.1016/j.lfs.2017.11.019 · 2018
Increased oxidative stress in obesity: Implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer
10.1016/j.orcp.2013.05.004 · 2013
10.3390/biom14060670
10.3390/biom14060670
PGC-1: The Energetic Regulator in Cardiac Metabolism
10.21775/cimb.028.029 · 2018
Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss
10.1016/j.molmet.2015.12.001 · doi-reference
Effects of maternal serine supplementation on high-fat diet-induced oxidative stress and epigenetic changes in promoters of glutathione synthesis-related genes in offspring
10.1016/j.jff.2018.05.067 · doi-reference
Obesity impairs cardiolipin-dependent mitophagy and therapeutic intercellular mitochondrial transfer ability of mesenchymal stem cells
10.1038/s41419-023-05810-3 · doi-reference
Dendritic peptide bolaamphiphiles for siRNA delivery to primary adipocytes
10.1016/j.biomaterials.2018.04.024 · doi-reference
MiR-125b affects mitochondrial biogenesis and impairs brite adipocyte formation and function
10.1016/j.molmet.2016.06.005 · doi-reference
Therapeutic Effects of Butyrate on Pediatric Obesity: A Randomized Clinical Trial
10.1001/jamanetworkopen.2022.44912 · doi-reference
Short-Chain Fatty Acids Protect Against High-Fat Diet-Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation
10.2337/db14-1213 · doi-reference
Butyrate stimulates adipose lipolysis and mitochondrial oxidative phosphorylation through histone hyperacetylation-associated β3-adrenergic receptor activation in high-fat diet-induced obese mice
10.1113/ep086114 · doi-reference
Sodium Butyrate Ameliorates High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease through Peroxisome Proliferator-Activated Receptor α-Mediated Activation of β Oxidation and Suppression of Inflammation
10.1021/acs.jafc.8b01189 · doi-reference
Butyrate Regulates Liver Mitochondrial Function, Efficiency, and Dynamics in Insulin-Resistant Obese Mice
10.2337/db16-0924 · doi-reference
10.3390/ijms23126367
10.3390/ijms23126367 · doi-reference
10.3389/fnut.2023.1104169
10.3389/fnut.2023.1104169 · doi-reference
Astaxanthin Attenuates Adiponectin, Calprotectin, miRNA222 and miRNA378 in Obesity induced by High-Fat Diet in Rats
10.2174/1389201022666210810105804 · doi-reference
Astaxanthin stimulates mitochondrial biogenesis in insulin resistant muscle via activation of AMPK pathway
10.1002/jcsm.12530 · doi-reference
10.3390/nu15020286
10.3390/nu15020286 · doi-reference
Effects of supplementation with curcuminoids on dyslipidemia in obese patients: A randomized crossover trial
10.1002/ptr.4715 · doi-reference
The Multifaceted Actions of Curcumin in Obesity
10.1007/978-3-030-73234-9_6 · doi-reference
Birth weight was negatively correlated with plasma ghrelin, insulin resistance, and coenzyme Q10 levels in overweight children
10.4162/nrp.2010.4.4.311 · doi-reference
Lycopene and tomato powder supplementation similarly inhibit high-fat diet induced obesity, inflammatory response, and associated metabolic disorders
10.1002/mnfr.201601083 · doi-reference
Lycopene supplementation attenuates western diet-induced body weight gain through increasing the expressions of thermogenic/mitochondrial functional genes and improving insulin resistance in the adipose tissue of obese mice
10.1016/j.jnutbio.2019.03.008 · doi-reference
Lycopene Improves Insulin Sensitivity through Inhibition of STAT3/Srebp-1c-Mediated Lipid Accumulation and Inflammation in Mice fed a High-Fat Diet
10.1055/s-0043-101919 · doi-reference
Resveratrol attenuates inflammation and oxidative stress in epididymal white adipose tissue: Implications for its involvement in improving steroidogenesis in diet-induced obese mice
10.1002/mrd.22478 · doi-reference
Gut microbiota-derived 4-hydroxyphenylacetic acid from resveratrol supplementation prevents obesity through SIRT1 signaling activation
10.1080/19490976.2024.2446391 · doi-reference
Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans
10.1016/j.cmet.2011.10.002 · doi-reference
Inhibition of mitochondrial fission by Drp-1 blockade by short-term leptin and Mdivi-1 treatment improves white adipose tissue abnormalities in obesity and diabetes
10.1016/j.phrs.2021.106028 · doi-reference
Pharmacological inhibition of dynamin-related protein 1 attenuates skeletal muscle insulin resistance in obesity
10.14814/phy2.14808 · doi-reference
10.1371/journal.pone.0060967
10.1371/journal.pone.0060967 · doi-reference
The Causal Role of Mitochondrial Dynamics in Regulating Insulin Resistance in Diabetes: Link through Mitochondrial Reactive Oxygen Species
10.1155/2018/7514383 · doi-reference
Colchicine’s effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: Results from a pilot randomized controlled trial
10.1038/s41366-020-0598-3 · doi-reference
MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
10.1038/s41589-019-0277-7 · doi-reference
Activation of the ROS/TXNIP/NLRP3 pathway disrupts insulin-dependent glucose uptake in skeletal muscle of insulin-resistant obese mice
10.1016/j.freeradbiomed.2024.06.011 · doi-reference
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease
10.1016/j.jdiacomp.2018.09.005 · doi-reference
Bardoxolone Methyl Prevents Fat Deposition and Inflammation in Brown Adipose Tissue and Enhances Sympathetic Activity in Mice Fed a High-Fat Diet
10.3390/nu7064705 · doi-reference
Bardoxolone methyl prevents obesity and hypothalamic dysfunction
10.1016/j.cbi.2016.07.013 · doi-reference
Redox regulation by NRF2 in aging and disease
10.1016/j.freeradbiomed.2019.01.016 · doi-reference
The role of the Nrf2/Keap1 signaling cascade in mechanobiology and bone health
10.1016/j.bonr.2021.101149 · doi-reference
Inhibition of DRP1-dependent mitochondrial fission by Mdivi-1 alleviates atherosclerosis through the modulation of M1 polarization
10.1186/s12967-023-04270-9 · doi-reference
Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance
10.7150/thno.50905 · doi-reference
10.3390/ani14010152
10.3390/ani14010152 · doi-reference
Dose translation between laboratory animals and human in preclinical and clinical phases of drug development
10.1002/ddr.21461 · doi-reference